Spondyloarthritis & psoriatic arthritis

Identification of circulating microRNA patterns in patients in psoriasis and psoriatic arthritis

Rheumatology (Oxford)Published Case-control biomarker study

Authors' conclusion

miRNA signatures in PsA and PsO patients differ from controls.

Study context

Population
Patients with PsA, psoriasis and healthy controls; serum miRNAs, hand MRI recordeddiscovery phase 48 samples
Participants
141 patients
Comparison
PsA vs psoriasis (PsO) vs healthy controls
  • PsAn = 51
  • PsOn = 40
  • Controlsn = 50reference
Outcome
Circulating miRNA signatures associated with PsO and PsA
Methodological detailsdiscovery and validation phases, RT-qPCR serum miRNA profiling
  • Discovery and validation phases
  • RT-qPCR serum miRNA profiling

Main finding

As reported in the abstract

Circulating miRNA signatures
Discovery: miRNAs down- or upregulated vs controls in PsO (adj. P < 0.05)
51
Discovery: miRNAs down- or upregulated vs controls in PsA (adj. P < 0.05)
64
Discovery: miRNAs changed in both PsO and PsA
33
Validation: miRNAs of 17 top candidates discriminating PsA and PsO from controls (AUC ≥0.70, all P < 0.05)
9
miRNAs significantly differently regulated between PsO and PsA (miR-19b-3p, miR-21-5p, miR-92a-3p, let-7b-5p)
4
AUC of combination of these 4 miRNAs to discriminate PsO and PsA (multivariate regression model)
0.92

Observational data: associations, not effects.

Original publication

Identification of circulating microRNA patterns in patients in psoriasis and psoriatic arthritis. Rheumatology (Oxford). Published 3 February 2023. doi:10.1093/rheumatology/kead059

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.